Literature DB >> 6189128

Unusual human interferons produced by virus-infected amniotic membranes.

P Duc-Goiran, B Robert-Galliot, T Chudzio, C Chany.   

Abstract

Interferon (IFN) induced in the human amniotic membrane contains at least five different molecular species, as shown by analysis in NaDodSO4/polyacrylamide gels after heating and under reducing conditions. Three of the IFN components reported here--migrating at 26, 43, and 80 kilodaltons--are of unusual antigenic structure because they are neutralized to about the same extent by anti-IFN-alpha and anti-IFN-beta antibodies. The 15- to 17-kilodalton species belongs to the IFN-alpha group, while the 21- to 22-kilodalton species, the most frequently detected major peak, is IFN-beta. In addition to their unusual size and antigenic structure, these IFNs could play a role during embryonic development and in the immune tolerance of the mother with regard to the fetus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189128      PMCID: PMC393880          DOI: 10.1073/pnas.80.9.2628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells.

Authors:  K PAUCKER; K CANTELL; W HENLE
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

2.  [Study of the mechanism of the refractory state of interferon producing cells, after repeated induction].

Authors:  C Chany; M Vignal
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1968-11-18

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Interferon effect on collagen and fibronectin distribution in the extracellular matrix of murine sarcoma virus-transformed cells.

Authors:  J Gerfaux; S Rousset; F Chany-Fournier; C Chany
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

5.  Interferon inhibits dimethyl sulphoxide-induced erythroid differentiation of Friend leukaemia cells.

Authors:  G B Rossi; G P Matarese; C Grappelli; F Belardelli; A Benedetto
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

6.  Human leukocyte interferon: relationship between molecular structure and species specificity.

Authors:  M N Thang; D C Thang; M K Chelbi-Alix; B Robert-Galliot; M J Commoy-Chevalier; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Identification of an interferon in murine placentas.

Authors:  A K Fowler; C D Reed; D J Giron
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

8.  Protective effect of interferon on target cells exposed to cellular cytotoxicity.

Authors:  M Bergeret; A Grégoire; C Chany
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

9.  Interferon effect on cytolytic T lymphocytes in a single cycle assay.

Authors:  M Bergeret; M Fouchard; A Gregoire; C Chany; D Zagury
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

10.  Reorganization of the cytoskeleton by interferon in MSV-transformed cells.

Authors:  M F Bourgeade; S Rousset; D Paulin; C Chany
Journal:  J Interferon Res       Date:  1981-02
View more
  3 in total

1.  Antitumor therapy based on the use of an immune modulator, arginine butyrate and interferon.

Authors:  C Chany; I Cerutti
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

2.  A neutrophil-derived antiviral protein: induction requirements and biological properties.

Authors:  H B Ohmann; M Campos; D R Fitzpatrick; N Rapin; L A Babiuk
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Unusual apparently constitutive interferons and antagonists in human placental blood.

Authors:  P Duc-Goiran; B Robert-Galliot; J Lopez; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.